Jason Cole, Chief Strategy & Financial Off at Bluebird Bio, holds 189.55K shares in Bluebird Bio (Ticker: BLUE), holds 15.09K shares in Epirus Biopharma (Ticker: EPRSQ). Most recently, Jason Cole Sold ― shares of Bluebird Bio on Aug 23, 2022 for an estimated value of 78.35K.